Skip to main content

Health Stocks in Motion

MGI Pharma and SuperGen fall on FDA communication.

Shares of

MGI Pharma





were among the most actively traded health-related stocks Friday, after the companies received an approvable letter from the Food and Drug Administration for Dacogen injection, which is used for the treatment of myelodysplastic syndromes.

The injection is approvable, MGI said, pending the FDA's review of a requested analysis of transfusion requirements of patients enrolled in the completed phase III trial, submission of other information and the completion of labeling discussions. "We are working diligently to complete the requested analysis of data and provide this information to the FDA as early as possible during the fourth," MGI Pharma said. Shares of MGI Pharma were recently trading down 32 cents, or 1%, to $26.72 while shares of SuperGen were trading down 37 cents, or 5%, to $6.60.



rose 1% after the specialty pharmaceutical company posted fourth-quarter earnings that were better than expected. Medicis earned $24.4 million, or 38 cents a share, on sales of $100.5 million. Excluding items, the company would have earned $27.8 million, or 43 cents a share. Analysts polled by Thomson First Call were expecting earnings of 41 cents a share on sales of $99.6 million. A year ago the company earned $23.7 million, or 34 cents a share, on sales of $88 million. Shares were trading up 32 cents to $34.27.

Shares of

Alexion Pharmaceuticals


fell 2% after the company said that it named Vikas Sinha as its new chief financial officer. Sinha replaces Carsten Boess, who resigned in March to pursue other opportunities. Sinha most recently served as CFO of Bayer Pharmaceuticals, a division of Germany's


Scroll to Continue

TheStreet Recommends


. Shares were recently trading down 47 cents to $28.59.

St. Jude Medical


rose modestly after the company received regulatory and reimbursement approvals to sell its Epic and Atlas implantable cardioverter defibrillator product families in Japan. This is the first time the company's ICDs have been available in Japan, the company said. Getz Brothers Co. Ltd. and Fukuda Denshi Co. Ltd. will distribute the devices. Shares were trading up 15 cents to $46.55.

Other health care volume movers included



, up 7 cents to $25.37;



, up 53 cents to $28.94;



, down 6 cents to $9.03;



, up 33 cents to $80.40;



, down 1 cent to $1.44;



, up 21 cents to $21.79;

Johnson & Johnson


, down 1 cent to $63.12;

Bristol-Myers Squibb


, up 22 cents to $24.63; and

Teva Pharmaceutical


, up 6 cents to $32.95.